Webb11 okt. 2024 · Clinical trials are studies of new mesothelioma treatment methods. People with mesothelioma may opt for a clinical trial for a chance to try new types of … Webb1 dec. 2024 · In the larger one, the DETERMINE trial, 571 pre-treated mesothelioma patients were randomized to receive ... V. van der Noort; P. Baas Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): Results of a prospective, single-arm, phase 2 trial., 2024, 7,pp. 260-270. DOI: https ...
National Center for Biotechnology Information
Webb20 apr. 2024 · Previously reported outcomes from the prospective, single-arm phase II INITIATE trial showed an ORR at 12 weeks of 29% with nivolumab plus ipilimumab in … Webb16 jan. 2024 · INITIATE was a prospective single-centre, single arm, phase 2 trial. Patients with malignant pleural mesothelioma who progressed after at least one line of platinum-containing chemotherapy were enrolled. richard ledbetter digital foundry
Immunotherapy with immune checkpoint inhibitors and predictive ...
Webb31 maj 2024 · Malignant pleural mesothelioma (MPM) is a rare and aggressive tumour. For patients with inoperable disease, few treatment options are available after first line … Webb14 apr. 2024 · According to its manufacturers, results from upcoming clinical trials will help determine a specific dosing schedule for the agent. Investigators plan to advance OM-301 through Good Manufacturing Practices toxicology, submit an investigational new drug application to the FDA, and initiate a first-in-human phase 1/2 clinical trial evaluating … Webb9 mars 2024 · First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2024;397(10272):375-386. doi:10.1016/S0140-6736(20)32714-8 PubMedGoogle ScholarCross 7. Wright red lion 4-20ma